186
Participants
Start Date
March 20, 2017
Primary Completion Date
February 27, 2018
Study Completion Date
February 27, 2018
ASP0819
Oral capsule
Placebo
Oral capsule
Site US10010 - Upstate Clinical Research Asc, Williamsville
Site US10005 - Charlottesville Med Research, Charlottesville
Site US10032 - Peters Medical Research, High Point
Site US10031 - Wake Research Associates, Raleigh
Site US10056 - Atlanta Ctr for Med Research, Atlanta
Site US10006 - Columbus Regional Research Ins, Columbus
Site US10024 - Compass Research LLC, Orlando
Site US10012 - Palm Beach Research Center, West Palm Beach
Site US10028 - Renstar Medical Research, Ocala
Site US10025 - Achieve Clinical Research, LLC, Birmingham
Site US10055 - Central Kentucky Research Asc, Lexington
Site US10037 - Dept of Psychiatry and Neuro University of Cincinnati, Cincinnati
Site US10019 - Lillestol Research LLC, Fargo
Site US10038 - Heartland Research Associates, Wichita
Site US10059 - Hillcrest Clinical, Oklahoma City
Site US10013 - Bateman Horne Center, Salt Lake City
Site US10018 - Altea Research Institute, Las Vegas
Site US10045 - TriWest Research Associates, El Cajon
Site US10003 - Artemis Inst For Clin Research, San Diego
Site US10048 - Diablo Clinical Research Inc, Walnut Creek
Site US10039 - Superior Research LLC, Sacramento
Site US10043 - Oregon Ctr for Clinical Invest, Portland
Site US10023 - Oregon Ctr for Clinical Invest, Salem
Site US10027 - BTC of New Bedford LLC, New Bedford
Astellas Pharma Global Development, Inc.
INDUSTRY